Skip to main content
. 2020 Mar 15;10(10):4606–4613. doi: 10.7150/thno.45016

Table 1.

Basal epidemic and clinical features of the patients

Basal Characteristics All Patients (n=118) Good Response (n=73) Poor/Fair Response (n=45) P
Sex 0.738
Male 60 (50.8) 38 (52.1) 22 (48.9)
Female 58 (49.2) 35 (47.9) 23 (51.1)
Age
Mean age ± SD 44.06±13.62 43.08±12.50 45.64±15.28 0.283
Range 2-75
≤20 3 (2.5)
21-40 48 (40.7)
41-50 31 (26.3)
51-60 18 (15.3)
61-70 17 (14.4)
≥70 1 (0.8)
Epidemic History
Direct exposure history 92 (78.0) 59 (80.8) 33 (73.3) 0.340
Indirect exposure history 24 (20.3) 13 (17.8) 11 (24.4) 0.384
Family outbreak 15 (12.7) 7 (9.6) 8 (17.8) 0.195
No exposure history 8 (6.8) 4 (5.5) 4 (8.9) 0.474
Onset symptoms
Fever 91 (77.1) 55 (75.3) 36 (80.0) 0.559
Cough 64 (54.2) 42 (57.5) 22 (34.4) 0.360
Myalgia or fatigue 23 (19.5) 12 (52.2) 11 (24.4) 0.286
Sore throat 13 (11.0) 8 (11.0) 5 (11.1) 0.980
Diarrhoea 6 (5.1) 3 (4.1) 3 (6.7) 0.539
Nausea and vomiting 3 (2.5) 1 (1.4) 2 (4.4) 0.303
Headache 4 (3.4) 2 (2.7) 2 (4.4) 0.619
Dyspnoea 1 (0.8) 0 (0) 1 (2.2) 0.201
More than one symptom 80 (67.8) 45 (61.6) 33 (73.3) 0.193
None 3 (2.5) 2 (2.7) 1 (2.2) 0.862
Underlying disease
Cardiovascular and cerebrovascular disease 18 (15.3) 13 (17.8) 5 (11.1) 0.326
Endocrine system and rheumatology disease 9 (7.6) 5 (6.8) 4 (8.9) 0.685
Surgery History 9 (7.6) 5 (6.8) 4 (8.9) 0.685
Digestive system disease 4 (3.4) 1 (1.4) 3 (6.7) 0.123
Respiratory system disease 4 (3.4) 1 (1.4) 3 (6.7) 0.123
Urinary system disease 2 (1.7) 0 (0) 2 (4.4) 0.069
None 81 (68.6) 52 (71.2) 29 (64.4) 0.440
Clinical type at baseline 0.329
Mild type 8 (6.8) 5 (6.8) 3 (6.7)
Common type 100 (84.7) 64 (87.7) 36 (80.0)
Severe type 10 (8.5) 4 (5.5) 6 (13.3)
Clinical outcome 0.000
Remained in hospital 76 (64.4) 34 (46.6) 42 (93.3)
Discharged 42 (35.6) 39 (53.4) 3 (6.7)

Note—Except for age (mean with SD in parentheses) data are number with percentage in parentheses